(Q34217892)

31 July 2017

1 reference

title

Oral contraceptives, thrombosis and haemostasis (English)

1 reference

31 July 2017

0 references

Rosing J

1

1 reference

31 July 2017

Curvers J

series ordinal

2

1 reference

31 July 2017

Tans G

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 April 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

31 July 2017

published in

1 reference

31 July 2017

volume

95

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

193-197

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

The 1995 pill scare revisited: anatomy of a non-epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Classification and comparison of oral contraceptives containing new generation progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Oral contraceptives and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Resistance to activated protein C in healthy women taking oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Activated protein C resistance caused by Arg506Gln mutation in factor Va

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Blood coagulation and oral contraceptives. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Bias versus causality: interpreting recent evidence of oral contraceptive studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Oral contraceptives and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900489-9

7 January 2021

10.1016/S0301-2115(00)00489-9

Identifiers

DOI

1 reference

31 July 2017

1 reference